Novartis

تفاصيل التقرير

ESG Index: Innovation

ESG Index: Innovation
Clinical trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a
particular disease or condition. These studies ensure that an investigative medicine is
effective and safe, and rely entirely on patients and healthy volunteers. For every
Novartis clinical trial our primary responsibility is to protect the safety, well-being and
legal rights of all participants and ensure adherence to the highest ethical standards for
clinical...
نوع التقرير
تقرير استدامة شامل
اللغة
الإنجليزية
السنة
الصيغة
PDF
معايير التقرير: GRI ISSB UN SDG
تنزيل التقرير